A review of atypical antipsychotics and their utility in post-traumatic stress disorder

3Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Post traumatic stress disorder (PTSD) is a chronic and debilitating mental illness. Atypical antipsychotics are often utilized for treatment of PTSD despite the limited data. The purpose of this article is to review published clinical trials of atypical antipsychotics used in the treatment of PTSD. Certain patients may benefit from therapy with an atypical antipsychotic, particularly for those with hyper-arousal or re-experiencing symptom clusters. At this time, guidelines suggest against the use of risperidone as augmentation therapy in patients with PTSD. Data are only available for olanzapine, quetiapine, and aripiprazole; however, data were conflicting, not very robust, and studies had limited sample sizes and narrow demographics. It is important to provide proper patient education and weigh the risks versus benefits of therapy with an atypical antipsychotic as metabolic side effects are well documented.

Cite

CITATION STYLE

APA

Connell, R., Zeier, K., & Thomas, C. J. (2013, January 1). A review of atypical antipsychotics and their utility in post-traumatic stress disorder. Mental Health Clinician. Allen Press Inc. https://doi.org/10.9740/mhc.n131049

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free